Detalhe da pesquisa
1.
Rationale and design of a study using a standardized locally procured macronutrient supplement as adjunctive therapy to HIV treatment in Kenya.
AIDS Care
; 25(9): 1138-44, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23320565
2.
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
Clin Drug Investig
; 37(3): 259-272, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066878
3.
Spatial clustering and epidemiological aspects of visceral leishmaniasis in two endemic villages, Baringo District, Kenya.
Am J Trop Med Hyg
; 74(2): 308-17, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16474089
4.
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya.
Am J Trop Med Hyg
; 73(5): 871-6, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16282296
5.
Perceptions of food-insecure HIV-positive adults participating in a food supplementation program in central Kenya.
J Health Care Poor Underserved
; 25(4): 1763-83, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25418241
6.
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
PLoS Negl Trop Dis
; 6(6): e1674, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22724029
7.
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
PLoS Negl Trop Dis
; 4(10): e709, 2010 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21049059